Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline
Description: PROJECT NARRATIVE Accelerated decline in physical function is a common adverse health effect of breast cancer chemotherapy linked to premature frailty, disability, and death. We hypothesize that targeting senescent cells, using exercise and treatments that ablate senescent cells, will improve chemotherapy-induced functional decline. If our hypothesis is correct, the impact on clinical practice would be substantial and will extend far beyond oncology.
Funder: National Cancer Institute
Funding type: research
Funder scheme: R01
Start date: 2023-09-01
End date: 2028-08-31
Investigator: MINA S SEDRAK (lead)
Institutions: University of California, Los Angeles, UNIVERSITY OF CALIFORNIA LOS ANGELES
Subfield: Cell Biology
Domain: Life Sciences
Funded outputs count: 13
Funder award ID: R01CA280088
OpenAlex ID: G9000874987
